1. Home
  2. KZIA vs DSS Comparison

KZIA vs DSS Comparison

Compare KZIA & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • DSS
  • Stock Information
  • Founded
  • KZIA 1994
  • DSS 1984
  • Country
  • KZIA Australia
  • DSS United States
  • Employees
  • KZIA N/A
  • DSS N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • DSS Containers/Packaging
  • Sector
  • KZIA Health Care
  • DSS Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • DSS Nasdaq
  • Market Cap
  • KZIA 6.0M
  • DSS 7.3M
  • IPO Year
  • KZIA 1999
  • DSS N/A
  • Fundamental
  • Price
  • KZIA $0.91
  • DSS $0.92
  • Analyst Decision
  • KZIA Strong Buy
  • DSS
  • Analyst Count
  • KZIA 2
  • DSS 0
  • Target Price
  • KZIA $11.50
  • DSS N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • DSS 19.0K
  • Earning Date
  • KZIA 03-26-2025
  • DSS 03-26-2025
  • Dividend Yield
  • KZIA N/A
  • DSS N/A
  • EPS Growth
  • KZIA N/A
  • DSS N/A
  • EPS
  • KZIA N/A
  • DSS N/A
  • Revenue
  • KZIA $1,655,324.00
  • DSS $25,019,000.00
  • Revenue This Year
  • KZIA $806.89
  • DSS N/A
  • Revenue Next Year
  • KZIA N/A
  • DSS N/A
  • P/E Ratio
  • KZIA N/A
  • DSS N/A
  • Revenue Growth
  • KZIA 248000.00
  • DSS N/A
  • 52 Week Low
  • KZIA $0.90
  • DSS $0.77
  • 52 Week High
  • KZIA $15.80
  • DSS $2.30
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 30.22
  • DSS 53.63
  • Support Level
  • KZIA $0.90
  • DSS $0.81
  • Resistance Level
  • KZIA $1.60
  • DSS $0.97
  • Average True Range (ATR)
  • KZIA 0.24
  • DSS 0.06
  • MACD
  • KZIA 0.02
  • DSS 0.01
  • Stochastic Oscillator
  • KZIA 2.87
  • DSS 68.18

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.

Share on Social Networks: